Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

(S)-3-(OH)-desazadesferrithiocin-polyether, magnesium salt

EU orphan designation number: EU/3/09/647   
Active ingredient: (S)-3-(OH)-desazadesferrithiocin-polyether, magnesium salt
Indication: Treatment of chronic iron overload requiring chelation therapy
Sponsor: Shire Pharmaceutical Development Limited
Hampshire International Business Park, Chineham, Basingstoke, Hampshire RG24 8EP, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/08/2009 Centralised Orphan - Designation EMEA/OD/008/09 (2009)6076 of 24/07/2009
01/03/2011 Other procedure EMEA/OD/008/09
02/08/2012 Centralised Orphan - Transfer of orphan designation EMEA/OD/008/09/T/01 (2012)5532 of 27/07/2012